Emeritus Faculty

Jean B. DeKernion, MD
Professor Emeritus of Urology and Chair of the UCLA Department for over 25 years, Dr. deKernion did his Residency at Case Western Reserve in Cleveland and his fellowship at the National Cancer Institute. Certified by the American Board of Surgery and American Board of Urology, Dr. deKernion is a World leader in Urologic Oncology, co-authoring the first textbook on the subject. Founder, Society of Urologic Oncology, member of the American Board of Urology, Chair, Department of Defense prostate cancer Research program, Dr. deKernion’s research included important advances in the treatment of patients with bladder, kidney and prostate cancer. To this day, the study and development of immune-based therapies pioneered by Dr. deKernion remain at the forefront of cancer research and reinforce the importance of his contributions. Dr. deKernion also worked tirelessly to build the department by recruiting and nurturing excellent faculty and educating students at all levels.

David J. Demanes, MD
Dr. Demanes received his bachelor of arts degree from UC Berkeley and his medical degree from the David Geffen School of Medicine at UCLA. He completed residencies in internal medicine and radiation oncology at UCLA and his medical oncology fellowship at UCSF. He is the past chairman and president of the American College of Radiation Oncology, who founded the California Endocurietherapy Center (CET) in 1981 and performed more than 10,000 surgical radiation implants. Dr. Demanes pioneered the use of high-dose-rate brachytherapy in prostate, head and neck, breast, GI, and gynecologic cancer with his research exploring the novel use of brachytherapy in the treatment of cancer.

Jonathan G. Braun, MD, PhD
Professor Emeritus of Pathology and Laboratory Medicine, and Molecular and Medical Pharmacology, Jonathan G. Braun, M.D., Ph.D., is a physician-researcher devoted to the roles of the immune system in resistance and susceptibility to inflammatory bowel disease and cancer. His recent national service includes chair of the National Scientific Advisory Committee of the Crohn's and Colitis Foundation; chair of the Scientific Board, Milieu Interieur, Institute Pasteur; president of the Clinical Immunology Society, and co-founder and president of the Federation of Clinical Immunology Societies, a leading international organization for translational immunology. Dr. Braun's research centers on the mechanisms of microbial-immune commensalism in the intestine and the integration of multi’omic and genetic analysis to advance the diagnosis and treatment of inflammatory bowel disease. The scope of this work includes functional immune assessment, tissue proteomics, genome-wide genetics, and microbiome metagenomics and metabolomics) and participation in the NIDDK IBD Genetics Consortium, NIH HMP2, and as PI of the CCFA Microbiome Consortium. His group is also devoted to new strategies in functional immune assessment, including gene targeting and positron-emission tomography for real-time imaging of immune-mediated inflammation. He has published more than 170 primary research studies, 14 issued patents, and co-founded three biotechnology companies.

UCLA Institute of Urologic Oncology

UCLA Institute of Urologic Oncology

Expert Team

Expert Team

Expert Team

Emeritus Faculty

UCLA Institute of Urologic Oncology

UCLA Institute of Urologic Oncology

Expert Team

Expert Team

Expert Team

Emeritus Faculty

Share this